May 6, 2019 Cellectar Reports First Quarter 2019 Financial Results and Provides a Corporate Update Learn More
Mar 19, 2019 FDA Grants Exemption to Import Alert for Cellectar’s CLR 131 in Pediatric and Adolescent Patients Learn More
Feb 26, 2019 Cellectar Reports Financial Results for Year Ended December 31, 2018 and Provides a Corporate Update Learn More
Feb 25, 2019 Cellectar Reports Positive Top-line Response Rate of 30% from R/R Multiple Myeloma Cohort in Ongoing Phase 2 Study of CLR 131 Learn More